EUVIMEDEUVIMED entdecken
Crossref

An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model

Yue Ma, Xianzhu Zhou, Yashi Liu, Shihan Xu, Aixia Ma, Yiqi Du iD, Hongchao Li

Helicobacter · 2024

DOI: 10.1111/hel.13123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Yue Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Cost-Benefit Analysis, Helicobacter pylori. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: 2023 Postgraduate Research & Practice Innovation Program of Jiangsu Province, Three-year Action Plan for the Construction of Shanghai's Public Health System (2023-2025), Shanghai Public Health Key Discipline Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is an economic evaluation on the family‐based Helicobacter pylori screen‐and‐treat strategy (FBHS) in China. This study aimed to compare the cost‐effectiveness of the FBHS with the traditional H. pylori screen‐and‐treat strategy (TBHS). Materials and Methods A seven‐state microsimulation model, including H. pylori infection and gastric cancer states, was constructed on the basis of the target family samples from 29 provinces in China. Taking a lifetime horizon from a healthcare system perspective, the long‐term costs and health outcomes of the FBHS and TBHS screening strategies were simulated separately, and economic evaluations were performed. The model parameters were primarily derived from real‐world data, published literature, and expert opinions. The primary outcome was the incremental cost‐effectiveness ratio (ICER) expressed as cost/quality‐adjusted life‐year (QALY) gained. One‐way sensitivity analysis, probabilistic sensitivity analysis, and scenario analysis were performed to assess the uncertainty of the results.

Results

The base‐case analysis revealed that the average costs for FBHS and TBHS were 563.67 CNY and 574.08 CNY, respectively, with corresponding average QALYs of 14.83 and 14.79. The ICER for the comparison between the two strategies was −214.07, indicating that FBHS was an absolutely dominant strategy with better cost‐effectiveness. The results of both one‐way sensitivity analysis and probabilistic sensitivity analysis were robust. When taking into account the added benefit of the higher H. pylori eradication rate in FBHS, the average costs were further reduced, and the average QALYs were increased, solidifying its position as an unequivocally dominant strategy.

Conclusion

The FBHS is an absolutely dominant and cost‐effective strategy that enables an optimized allocation of screening resources. Decision‐makers should prioritize FBHS when developing H. pylori prevention and control strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsCost-Benefit AnalysisHelicobacter pyloriHumansChinaMass ScreeningMiddle AgedQuality-Adjusted Life YearsMaleFemaleAdultComputer SimulationStomach Neoplasms

Stichwörter der Autor:innen

Helicobacter pyloricost‐utility analysiseconomic evaluationfamily‐based screeningmicrosimulationreal‐world study

Autor:innen und Institutionen

  • School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
  • Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.
  • Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.

ORCID-Profile: Yiqi Du

Förderung

  • 2023 Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Three-year Action Plan for the Construction of Shanghai's Public Health System (2023-2025)
  • Shanghai Public Health Key Discipline Project

Zitieren

APA

Ma, Y., Zhou, X., Liu, Y., Xu, S., Ma, A., Du, Y., & Li, H. (2024). An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model. Helicobacter. https://doi.org/10.1111/hel.13123

Vancouver

Ma Y, Zhou X, Liu Y, Xu S, Ma A, Du Y, et al. An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model. Helicobacter. 2024. doi:10.1111/hel.13123

BibTeX
@article{Ma2024,
  author = {Ma, Yue and Zhou, Xianzhu and Liu, Yashi and Xu, Shihan and Ma, Aixia and Du, Yiqi and Li, Hongchao},
  title = {An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13123}
}
Kostenlos starten →